Company intelligence / Profile preview

Gotvoom

Seattle, Washington, United States

Ownership: Private
Development stage: Other

Overview

GotVoom is a biotechnology company based in Seattle, Washington, dedicated to addressing age-related muscle loss and sarcopenia. The company develops proprietary formulations that target mitochondrial function and muscle protein synthesis to improve physical performance and mobility in older adults. GotVoom's lead program is a novel nutritional therapeutic that has undergone clinical testing in collaboration with the University of Washington. By focusing on the biological mechanisms of muscle aging, the company aims to enhance the healthspan and quality of life for the elderly population.

Therapeutic areas: NeurologyMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Partnerships

University of Washington

Beyond the preview

Go deeper on Gotvoom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gotvoom.

Explore the full profile